Importer of Controlled Substances; Notice of Registration; Johnson Matthey, Inc., 14296-14297 [2014-05488]

Download as PDF 14296 Federal Register / Vol. 79, No. 49 / Thursday, March 13, 2014 / Notices DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration; GE Healthcare Importer of Controlled Substances; Notice of Registration; Siegfried USA, LLC Importer of Controlled Substances; Notice of Registration; Johnson Matthey, Inc. By Notice dated December 23, 2013, and published in the Federal Register on January 10, 2014, 79 FR 1887, Siegfried USA, LLC., 33 Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: By Notice dated November 4, 2013, and published in the Federal Register on November 18, 2013, 78 FR 69130, Johnson Matthey, Inc., Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, New Jersey 08066–1742, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: By Notice dated November 2, 2013, and published in the Federal Register on November 19, 2013, 78 FR 69447, GE Healthcare, 3350 North Ridge Avenue, Arlington Heights, Illinois 60004–1412, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Cocaine (9041), a basic class of controlled substance listed in schedule II. The company plans to import small quantities of ioflupane, in the form of three separate analogues of Cocaine, that will be used for the support and manufacture of DaTSCAN (ioflupane I– 123) injections for distribution as a radioactive diagnostic imaging agent utilized in the diagnosis of Parkinson’s disease. No comments or objections have been received. The DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of GE Healthcare to import the basic class of controlled substance is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA has investigated GE Healthcare to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. TKELLEY on DSK3SPTVN1PROD with NOTICES Dated: February 19, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2014–05480 Filed 3–12–14; 8:45 am] BILLING CODE 4410–09–P Drug Schedule Opium, raw (9600) ....................... Poppy Straw Concentrate (9670) II II The company plans to import the listed controlled substances to bulk manufacture APIs for distribution to its customer. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417 (January 25, 2007). The DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Siegfried USA, LLC., to import the basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA has investigated Siegfried USA, LLC., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: February 19, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2014–05497 Filed 3–12–14; 8:45 am] BILLING CODE 4410–09–P VerDate Mar<15>2010 17:33 Mar 12, 2014 Jkt 232001 PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 Drug Coca Leaves (9040) ..................... Thebaine (9333) ........................... Opium, raw (9600) ....................... Noroxymorphone (9668) .............. Poppy Straw Concentrate (9670) Schedule II II II II II The company plans to import the listed controlled substances as raw materials, to be used in the manufacture of bulk controlled substances, for distribution to its customers. Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417, (January 25, 2007). In reference to the non-narcotic raw material, no comments or objections have been received. The company plans to import gram amounts to be used as reference standards for distribution to its customers. The DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Johnson Matthey, Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA has investigated Johnson Matthey, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. E:\FR\FM\13MRN1.SGM 13MRN1 14297 Federal Register / Vol. 79, No. 49 / Thursday, March 13, 2014 / Notices Dated: February 19, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration; Johnson Matthey, Inc. [FR Doc. 2014–05488 Filed 3–12–14; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application; Cayman Chemical Company Pursuant to 21 CFR 1301.33(a), this is notice that on December 6, 2013, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made application by correspondence to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule 2-(4-bromo-2,5-dimethoxyphenyl)N-(2-methoxybenzyl) (25B– NBOMe) (7536). 2-(4-chloro-2,5-dimethoxyphenyl)N-(2-methoxybenzyl) (25C– NBOMe) (7537). 2-(4-iodo-2,5-dimethoxyphenyl)-N(2-methoxybenzyl) (25I– NBOMe) (7538). I I I TKELLEY on DSK3SPTVN1PROD with NOTICES The company plans to manufacture the listed controlled substances, and distribute those substances to its research and forensics customers for drug testing and analysis. Any other such applicant, and any person who is presently registered with the DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODW), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than May 12, 2014. Dated: Signed February 19, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2014–05493 Filed 3–12–14; 8:45 am] BILLING CODE 4410–09–P VerDate Mar<15>2010 17:33 Mar 12, 2014 Jkt 232001 By Notice dated November 5, 2013, and published in the Federal Register on November 18, 2013, 78 FR 69132, Johnson Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066–1742, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: February 19, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2014–05503 Filed 3–12–14; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Schedule Gamma Hydroxybutyric Acid (2010). Tetrahydrocannabinols (7370) ..... Dihydromorphine (9145) ............... Difenoxin (9168) ........................... Propiram (9649) ........................... Amphetamine (1100) .................... Methamphetamine (1105) ............ Lisdexamfetamine (1205) ............. Methylphenidate (1724) ................ Nabilone (7379) ............................ Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Diphenoxylate (9170) ................... Ecgonine (9180) ........................... Hydrocodone (9193) ..................... Meperidine (9230) ........................ Methadone (9250) ........................ Methadone intermediate (9254) ... Morphine (9300) ........................... Thebaine (9333) ........................... Oxymorphone (9652) ................... Noroxymorphone (9668) .............. Alfentanil (9737) ........................... Remifentanil (9739) ...................... Sufentanil (9740) .......................... Tapentadol (9780) ........................ Fentanyl (9801) ............................ I I I I I II II II II II II II II II II II II II II II II II II II II II II II II II The company plans to manufacture the listed controlled substances in bulk for sale to its customers. No comments or objections have been received. The DEA has considered the factors in 21 U.S.C. 823(a), and determined that the registration of Johnson Matthey, Inc., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. The DEA has investigated, Johnson Matthey, Inc., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 Manufacturer of Controlled Substances; Notice of Registration; Cedarburg Pharmaceuticals, Inc. By Notice dated October 16, 2013, and published in the Federal Register on October 25, 2013, 78 FR 64017, Cedarburg Pharmaceuticals, Inc., 870 Badger Circle, Grafton, Wisconsin 53024, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug 4-Anilino-N-phenethyl-4-piperidine (8333). Remifentanil (9739) ...................... Fentanyl (9801) ............................ Schedule II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. No comments or objections have been received. The DEA has considered the factors in 21 U.S.C. 823(a), and determined that the registration of Cedarburg Pharmaceuticals, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. The DEA has investigated Cedarburg Pharmaceuticals, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a) and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. E:\FR\FM\13MRN1.SGM 13MRN1

Agencies

[Federal Register Volume 79, Number 49 (Thursday, March 13, 2014)]
[Notices]
[Pages 14296-14297]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05488]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; 
Johnson Matthey, Inc.

    By Notice dated November 4, 2013, and published in the Federal 
Register on November 18, 2013, 78 FR 69130, Johnson Matthey, Inc., 
Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, New Jersey 
08066-1742, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as an importer of the following 
basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Coca Leaves (9040).........................  II
Thebaine (9333)............................  II
Opium, raw (9600)..........................  II
Noroxymorphone (9668)......................  II
Poppy Straw Concentrate (9670).............  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances as raw 
materials, to be used in the manufacture of bulk controlled substances, 
for distribution to its customers.
    Comments and requests for hearings on applications to import 
narcotic raw material are not appropriate. 72 FR 3417, (January 25, 
2007).
    In reference to the non-narcotic raw material, no comments or 
objections have been received. The company plans to import gram amounts 
to be used as reference standards for distribution to its customers.
    The DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) 
and determined that the registration of Johnson Matthey, Inc. to import 
the basic classes of controlled substances is consistent with the 
public interest and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971. The DEA 
has investigated Johnson Matthey, Inc. to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 
1301.34, the above named company is granted registration as an importer 
of the basic classes of controlled substances listed.


[[Page 14297]]


    Dated: February 19, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2014-05488 Filed 3-12-14; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.